Development and Application of a Validated UHPLC Method for the Determination of Atropine and Its Major Impurities in Antidote Treatment Nerve Agent Auto-Injectors (ATNAA) Stored in the Strategic National Stockpiles — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Development and Application of a Validated UHPLC Method for the Determination of Atropine and Its Major Impurities in Antidote Treatment Nerve Agent Auto-Injectors (ATNAA) Stored in the Strategic National Stockpiles
Office of Regulatory Affairs, Detroit Laboratory, Food and Drug Administration, Detroit, MI, USA
,
Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
,
Office of Regulatory Affairs, Detroit Laboratory, Food and Drug Administration, Detroit, MI, USA
,
Office of Regulatory Affairs, Detroit Laboratory, Food and Drug Administration, Detroit, MI, USA
,
Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
,
Office of Regulatory Affairs, Detroit Laboratory, Food and Drug Administration, Detroit, MI, USA
,
Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
,
Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
1 Office of Regulatory Affairs, Detroit Laboratory, Food and Drug Administration, Detroit, MI, USA
2 Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
3 Office of Regulatory Affairs, Detroit Laboratory, Food and Drug Administration, Detroit, MI, USA
4 Office of Regulatory Affairs, Detroit Laboratory, Food and Drug Administration, Detroit, MI, USA
5 Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
6 Office of Regulatory Affairs, Detroit Laboratory, Food and Drug Administration, Detroit, MI, USA
7 Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
8 Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
The development and implementation of advanced analytical technologies is essential for extending the expiry for complex drug products stored in the Strategic National Stockpiles. Consequently, a novel Ultra High-Performance Liquid Chromatographic (UHPLC) method has been developed for the analysis of atropine and its respective impurities to support the analytical research platform for auto-injectors. This study is part of a larger research effort to improve the efficiency and broaden the applicability of advanced analytical methods for medical counter-measure medications. The current HPLC compendial methodology for atropine sulfate injection requires an analysis time of 40 minutes for atropine. In comparison, the novel gradient UHPLC method required only 8 minutes to evaluate both atropine and its major pharmaceutical impurities. Improved separation was achieved on a Waters Acquity UHPLC BEH C18 1.7 μm, 2.1 × 100 mm column employing gradient elution of mobile phase solvent A (0.1% H 3 PO 4 ) and solvent B (0.1% H 3 PO 4 , 90% ACN, and 10% H 2 O). The method was validated according to USP Category I requirements for assay. The daily standard calibration curves were linear over a concentration range from 50 μg/mL to 250 μg/mL with a correlation coefficient of >0.999. The detection limit (LOD) and quantitation limit (LOQ) were 3.9 μg/ml and 13.1 μg/ml, respectively. Resolution results indicate that atropine and the following impurities, degradants and a preservative can also be separated and analyzed using this proposed method: noratropine, 4,4’-di-hy-droxydiphenyl ether, 2,4’-dihydroxydiphenyl ether, 4-bromophenol, 4-hydro-xyatropine, tropic acid, apoatropine HCl, atropic acid, hydroquinone, nitroethane, phenol and catechol. The UHPLC method demonstrated enhanced selectivity and significantly reduced the analysis time when compared with the traditional USP compendial HPLC method. The method was successfully applied to the evaluation of atropine in ATNAA auto-injectors lots from the Strategic National Stockpiles.
Lyon, R., et al. (2006) Stability Profiles of Drug Products Extended beyond Labeled Expiration Dates. Journal of Pharmaceutical Sciences, 95, 1549-1560. https://doi.org/10.1002/jps.20636
Cantrell, L., et al. (2012) Stability of Active Ingredients in Long-Expired Prescription Medications. Archives of Internal Medicine, 172, 1685-1687. https://doi.org/10.1001/archinternmed.2012.4501
Khan, S.R., Kona, R., Faustino, P.J., Gupta, A., Taylor, J.S., Porter, D.A., et al. (2014) United States Food and Drug Administration and Department of Defense Shelf-Life Extension Program of Pharmaceutical Products: Progress and Promise. Journal of Pharmaceutical Sciences, 103, 1331-1336. https://doi.org/10.1002/jps.23925
Khan, S.R., Mohammad, A., Khan, M.A. and Faustino, P.J. (2016) Critical Importance and Quality Evaluation of Drug Delivery Autoinjectors in the FDA-DOD Shelf Life Extension Program (SLEP). The AAPS Journal, 18, 801-803. https://doi.org/10.1208/s12248-016-9910-5
Dix, J., Weber, R.J., Frye, R.F., Nolin, T.D., et al. (2003) Stability of Atropine Sulfate Prepared for Mass Chemical Terrorism. Journal of Toxicology: Clinical Toxicology, 41, 771-775. https://doi.org/10.1081/CLT-120025341
Rebmann, T., Clements, B.W., Bailey, J.A. and Evans, R.G. (2009) Organophosphate Antidote Auto-Injectors vs. Traditional Administration: A Time Motion Study. The Journal of Emergency Medicine, 37, 139-143. https://doi.org/10.1016/j.jemermed.2007.09.043
Namba, T. and Hiraki, K. (1958) PAM (Pyridine-2-Aldoxime Methiodide) Therapy for Alkyl-Phosphate Poisoning. Journal of American Medical Association, 166, 1834-1839. https://doi.org/10.1001/jama.1958.02990150030007
Gunderson, C.H. and Lehmann, C.R. (1992) Nerve Agents: A Review. Neurology, 42, 946-950. https://doi.org/10.1212/WNL.42.5.946
Vijayaraghavan, R. and Jain, N. (2007) Evaluation of the Antidotal Efficacy of Atropine Sulphate and Pralidoxime Chloride Given by Autoinjectors against Nerve Agent (Sarin) Toxicity. Journal of Medicine C.B.R. Def., 5, 1-12.
Vijayaraghavan, R. and Bhaskar, A.S.B. (2012) A Convenient First Aid Kit for Chemical and Biological Agents and Radiation Exposure. Journal of Environmental Biology, 33, 673-681.
Namba, T. (1971) Poisoning Due to Organophosphate Insecticides. Acute and Chronic Manifestations. American Journal of Medicine, 50, 475-492. https://doi.org/10.1016/0002-9343(71)90337-8
Schroeder, A.C. (1989) Pralidoxime Chloride Stability-Indicating Assay and Analysis of Solution Samples Stored at Room Temperature for Ten Years. Journal of Pharmaceutical Sciences, 78, 132-136. https://doi.org/10.1002/jps.2600780212
Schier, J.G. (2004) Preparing for Chemical Terrorism: Stability of Injectable Atropine Sulfate. Academy of Emerging Medicine, 11, 329-334. https://doi.org/10.1111/j.1553-2712.2004.tb01447.x
Loch, M. (2007) Atropine Degradation Products and Trace Heavy Metal Content in AtroPenW and ComboPenW Auto-Injectors. Toxicology, 233, 229-230. https://doi.org/10.1016/j.tox.2006.04.015
O’Neil, M.J. (2006) The Merck Index. 14th Edition, Merck and Co., Whitehouse Station, 873.
Kirchhoff, C., Bitar, Y., Ebel, S. and Holzgrabe, U. (2004) Analysis of Atropine, Its Degradation Products and Related Substances of Natural Origin by Means of Reversed-Phase High-Performance Liquid Chromatography. Journal of Chromatography A, 1046, 115-120. https://doi.org/10.1016/j.chroma.2004.05.088
Van Der Meer, M.J. (1983) Preparation of Noratropine by Oxidative N-Dmethylation of Atropine. Journal of Pharmacy and Pharmacology, 35, 408. https://doi.org/10.1111/j.2042-7158.1983.tb02975.x
GÖren, A.C. (2004) Simple High-Performance Liquid Chromatographic Method for Determination of Atropine and Obidoxime in a Parenteral Injection Device. Journal of Chromatography A, 1057, 237-239. https://doi.org/10.1016/j.chroma.2004.09.048
Lau, O.W. and Mok, C.S. (1997) High-Performance Liquid Chromatographic Determination of Atropine and Atropine-Like Alkaloids in Pharmaceutical Preparations with Indirect Conductometric Detection. Journal of Chromatography A, 766, 270-276. https://doi.org/10.1016/S0021-9673(96)01019-9
Paddle, B.M. and Dowling, M.H. (1993) Simple High-Performance Liquid Chromatographic Method for Assessing the Deterioration of Atropine-Oxime Mixtures Employed as Antidotes in the Treatment of Nerve Agent Poisoning. Journal of Chromatography A, 648, 373-380. https://doi.org/10.1016/0021-9673(93)80419-9
Pohjola, J. and Harpf, M. (1994) Determination of Atropine and Obidoxime in Automatic Injection Devices Used as Antidotes against Nerve Agent Intoxication. Journal of Chromatography A, 686, 350-354. https://doi.org/10.1016/0021-9673(94)00780-2
Takahashi, M. (1997) Determination of Atropine in Pharmaceutical Preparations by Liquid Chromatography with Fluorescence Detection. Journal of Chromatography A, 775, 137-141. https://doi.org/10.1016/S0021-9673(97)00305-1
Walters, M.J. (1978) High Pressure Liquid Chromatographic Determination of Atropine Sulfate and Scopolamine Hydrobromide in Tablets. Journal—Association of Official Analytical Chemists, 61, 1428-1432.
Zimmermann, T. (2012) Rapid Resolution Liquid Chromatography for Monitoring the Quality of Stockpiled Atropine Preparations for Injection. Drug Testing and Analysis, 4, 222-228. https://doi.org/10.1002/dta.402
Chandarana, C. (2016) UPLC: A Prominent Analytical Technique for Pharmaceuticals. International Journal of Pharmaceutical Sciences Review and Research, 37, 192-201.
Chen, H.X., Chen, Y., Du, P. and Han, F.M. (2007) LC-MS for Identification and Elucidation of the Structure of In-Vivo and In-Vitro Metabolites of Atropine. Chromatographia, 65, 413-418. https://doi.org/10.1365/s10337-007-0187-9
Russo, R. (2008) Pharmaceutical Applications on Columns Packed with Sub-2 μm Particles. Journal of Chromatographic Science, 46, 99-208. https://doi.org/10.1093/chromsci/46.3.199
Nguyen, D.T. (2006) Fast Analysis in Liquid Chromatography Using Small Particle Size and High Pressure. Journal of Separation Science, 29, 1836-1848. https://doi.org/10.1002/jssc.200600189
Mazzeo, J.R. (2005) Advancing LC Performance with Smaller Particles and Higher Pressure. Analytical Chemistry, 77, 460A-467A. https://doi.org/10.1021/ac053516f
Villiers, A.D. (2006) Evaluation of Ultra Performance Liquid Chromatography: Part I. Possibilities and Limitations. Journal of Chromatography A, 1127, 60-69. https://doi.org/10.1016/j.chroma.2006.05.071
Wren, S.A.C. (2006) Use of Ultra-Performance Liquid Chromatography in Pharmaceutical Development. Journal of Chromatography A, 1119, 140-146. https://doi.org/10.1016/j.chroma.2006.02.052
Arvadiya, A.C. (2013) Development and Validation of Novel RP-UPLC Method for Estimation of Atropine Sulphate in Pharmaceutical Dosage Form. Chemical Industry & Chemical Engineering Quarterly, 19, 333-337. https://doi.org/10.2298/CICEQ120319068A
USP 39-NF 34 (2016) United States Pharmacopeia 1225 Validation of Compedial Procedures. USP, 1-10.
USP 39-NF 34 (2016) United States Pharmacopeia 621 Validation of Compedial Procedures. USP, 1-7.